Updated Guidelines on Optimal Antibiotic Dosing for Patients With Obesity
Researchers evaluated clinical trial data and drug databases to provide updated recommendations on antimicrobial dosing for patients with obesity.
Diagnosis & Disease Information
The Last of Us: Separating Fungal Fact From Fiction
Anne Meneghetti, MD, juxtaposes the portrayal of fungal infections in HBO’s The Last of Us with real-world concerns about rising rates of antimicrobial resistance.
Fiber Supplementation May Decrease Diarrhea Risk for Inpatients on Enteral Nutrition
Researchers evaluated the effects of fiber supplementation on the risk for diarrhea among hospitalized patients receiving enteral nutrition.
WHO Global Arborvirus Initiative: Where do Infectious Disease Providers Play a Role?
Karen Krueger, MD, provides insight into the role Infectious Disease providers can play in the World Health Organization’s recently announced Global Arborvirus Initiative.
Positive Outcomes From an Infectious Disease Crisis
No crisis should go unexploited for its potential to improve health care delivery.
The Case for Expanding Pharmacists’ Authority to Administer Vaccines
Dr Robert Popovian discusses access to immunization services among adults in low-income communities and efforts to expand pharmacists’ authority to administer vaccines to increase vaccination rates for this vulnerable population.
And Then Came Monkeypox: What to Know About the Recent Outbreak
In this interview, Paritosh Prasad, MD, provides insight into the recent outbreak of monkeypox.
Adjuvanted Enterovirus 71 Vaccine Is Highly Effective in Infants and Children
Researchers assessed the efficacy of an adjuvanted enterovirus 71 (EV71) vaccine for the prevention of EV71-associated infections among infants and children.
Combine and Conquer: A Treatment Strategy to Combat Drug-Use Associated Infections
Sandra Springer, MD, and Laura Marks, MD, PhD, highlight the need for a combined treatment approach for patients with drug-use associated infections.
Novel Microbiome Therapy Reduces Risk for Recurrent C difficile Infection
Investigators assessed the efficacy of a novel microbiome therapeutic, SER-109, for the treatment of recurrent C difficile infection.
- Loading...
Loading...
Next post in Medicine
Loading... 
Loading...